糖基化修饰高保真人源肺脏类器官构建
首发时间:2024-04-11
摘要:肺癌作为全世界范围内致死率最高的恶性肿瘤,其中肺腺癌是非小细胞肺癌中最常见亚型,也是体细胞基因畸变研究最为广泛的肺癌亚型。来自成体干细胞的肿瘤类器官作为一种构建成功率相对较高的体外模型,其一定程度上保留了原始组织的基因和组织特征。但作为与肿瘤发生密切相关的糖基化修饰,目前尚不清楚其与原始组织的相似性。本研究主要通过转录组学,糖蛋白组学等多组学联合分析方法,深入研究了类器官基因表达和蛋白质糖基化修饰分子层面上与原始组织的相似性。 目的:为了明确成体干细胞来源的类器官在3D培养过程中,对原始组织基因表达和其糖基化修饰的保留程度,指导建立能够更加保持肿瘤原始组织功能形态和分子特征的肿瘤类器官。 方法:本研究利用深度转录组学、TMT标记定量糖蛋白组学和糖基化修饰预测工具GlycoMaple解析等多组学联合分析方法来对类器官和原始组织进行包括形态学表征,肿瘤标志物鉴定、基因表达、蛋白质水平及其糖基化修饰水平进行联合分析。 结果:通过形态学检测证明肺腺癌类器官为囊性结构,并且明确了其具有关键的分子病理特征(Napsin A+,CK7+,TTF1+,P40-)和肺气管的细胞亚型组成(基底细胞,纤毛细胞,杯状细胞)。通过类器官与原始组织的多组学联合分析,证明类器官在分子层面与原始组织的相似性,其中转录水平相似度大于80%,蛋白质糖链种类完全相同且48%的丰度趋势一致,且原始组织中91%的高转录比蛋白与类器官相同。类器官差异性主要体现在免疫微环境细胞的部分缺失,岩藻糖和唾液酸化丰度升高,特有高转录比糖蛋白主要参与肿瘤经典通路PI3K/AKT的激活和细胞粘附等。本研究结果表明类器官是一种能够模拟原始组织糖基化修饰的高保真3D培养模型,且具有比原始组织更高癌症纯度的特征。
For information in English, please click here
Construction of glycosylation high fidelity human lung organoids
Abstract:Lung cancer, as the malignant tumor with the highest mortality rate worldwide, among which lung adenocarcinoma is the most common subtype of non-small cell lung cancer and the most widely studied subtype of lung cancer with somatic gene aberrations. Tumor organoids derived from adult stem cells, as an in vitro model with a relatively high success rate, retain to some extent the genes and tissue characteristics of the original tissue. However, as a glycosylation modification closely related to tumor development, its similarity with the original tissue is currently unclear. This study mainly used a combination of transcriptomics, proteomics, and other omics analysis methods to investigate the similarities and differences between organoid gene expression and protein glycosylation modification at the molecular level and the original tissue. Purpose: To clarify the degree of preservation of gene expression and glycosylation modifications in the original tissue of adult stem cell-derived organoids during 3D culture, and to guide the establishment of tumor organoids that can better maintain the original tissue morphology and molecular characterization of tumors. Method: This study utilized multiple omics joint analysis methods such as deep transcriptomics, TMT labeled quantitative proteomics, and glycation modification prediction tool GlycoMaple analysis to perform morphological characterization, tumor marker identification, gene expression, protein level, and glycation modification level analysis on organoids and primitive tissues. Results: Morphological examination confirmed that lung adenocarcinoma like organs have a cystic structure and identified their key molecular pathological features (Napsin A+, CK7+, TTF1+, P40-) and cellular subtypes of the lung and trachea (basal cells, ciliated cells, goblet cells). Through multi omics joint analysis of organoids and primitive tissues (transcriptomics and proteomics), it was demonstrated that organoids are consistent with primitive tissues at the molecular level, with transcriptional similarity greater than 80%, 48% of sugar chains showing no significant differences, and 91% of high transcriptional proteins in primitive tissues consistent with organoids. The differences are mainly reflected in the absence of immune microenvironment, the orientation of glycoschain synthesis in organoids is high fucose and sialylation, and the high transcriptional ratio glycoproteins unique to organoids are mainly involved in the activation of the classic tumor pathway PI3K/AKT and cell adhesion. The results of this study demonstrate that organoids are a high fidelity 3D culture model that can simulate glycosylation modifications in primitive tissues and have higher purity characteristics than primitive tissues.
Keywords: Proteomic Glycosylation Organoid Multiomics
基金:
引用
No.****
动态公开评议
共计0人参与
勘误表
糖基化修饰高保真人源肺脏类器官构建
评论
全部评论0/1000